Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis

Saved in:
Bibliographic Details
Published in:Leukemia 2023-07, Vol.37 (7), p.1558-1560
Main Authors: Diamond, Akiva, Vu, Long, Bensken, Wyatt P., Koroukian, Siran M., Caimi, Paolo F.
Format: Article
Language:English
Subjects:
692/699/1541/1990/283/1895
692/699/67/1059/99
Age
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cancer Research
Cancer therapies
Chemotherapy
Chlorambucil
Chlorambucil - therapeutic use
Chronic lymphocytic leukemia
Clinical trials
Critical Care Medicine
Disease-Free Survival
Enrollments
FDA approval
Frailty
Government programs
Hematology
Humans
Intensive
Internal Medicine
Letter
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
Lymphatic leukemia
Medicare
Medicine
Medicine & Public Health
Oncology
Rituximab - therapeutic use
United States
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0887-6924
1476-5551
1476-5551
DOI:10.1038/s41375-023-01915-y